SEC Info - Alterra Healthcare Corp - ‘15-12B’ on 12/5/03

Alterra Healthcare Corp – ‘15-12B’ on 12/5/03

Alterra Healthcare Corp – ‘15-12B’ on 12/5/03

On: Friday, 12/5/03, at 5:11pm ET · Effective: 12/5/03 · Accession #: 950144-3-13457 · File #: 1-11999

Certification of Termination of Registration of a Class of Securities — Form 15
Filing Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein

On: Friday, 12/5/03, at 5:11pm ET · Effective: 12/5/03 · Accession #: 950144-3-13457 · File #: 1-11999

Certification of Termination of Registration of a Class of Securities — Form 15Filing Table of Contents

This is an HTML Document rendered as filed. [ Alternative Formats ]

Dates Referenced Herein

Certification of Termination of Registration of a Class of Securities — Form 15
Filing Table of Contents

SEC Info℠

Home

Help

Please Sign In

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

12/05/03  Alterra Healthcare Corp           15-12B     12/05/03    1:9K                                     Bowne of Atlanta Inc/FA

Document/Exhibit                   Description                      Pages   Size 

 1: 15-12B      Alterra Healthcare Corporation                      HTML     11K

e15v12b

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 15

Certification and Notice of Termination of Registration

under Section 12(g) of the Securities Exchange Act of 1934

or Suspension of Duty to File Reports Under Sections 13

and 15(d) of the Securities Exchange Act of 1934

Commission File No. 1-12000

Alterra Healthcare Corporation

(Exact name of registrant as specified in its charter)

10000 Innovation Drive, Milwaukee, WI 53226 (414) 918-5000

(Address, including zip code and telephone number, including

area code, of registrant’s principal executive offices)

Common Stock, $.01 par value per share

(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty

to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:


Rule 12g-4(a)(1)(i)	x	Rule 12h-3(b)(1)(ii)	o
Rule 12g-4(a)(1)(ii)	o	Rule 12h-3(b)(2)(i)	o
Rule 12g-4(a)(2)(i)	o	Rule 12h-3(b)(2)(ii)	o
Rule 12g-4(a)(2)(ii)	o	Rule 15d-6	o
Rule 12h-3(b)(1)(i)	x

Approximate number of holders of record as of the certification or notice date: One (1)

Pursuant to the requirements of the Securities Exchange Act of 1934, Alterra Healthcare Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

This ‘15-12B’ Filing	Date	Other Filings

Filed on / Effective on:	12/5/03	None on these Dates
		List all Filings

↑Top

Filing Submission 0000950144-03-013457 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

December 5, 2003

-s- Mark W. Ohlendorf

Name: Mark W. Ohlendorf
Title: President, Chief Financial Officer and Secretary